Cannon Stephen N

Director at Archimedes Tech SPAC Partners II Co. · on record since Feb 10, 2025
Vice President of Acquisitions at Troops, Inc. /Cayman Islands/ · on record since Mar 7, 2008
10% owner at Troops, Inc. /Cayman Islands/ · on record since Mar 7, 2008
Director at Roan Holdings Group Co., Ltd. · on record since Sep 30, 2014
President/CEO at Roan Holdings Group Co., Ltd. · on record since Sep 30, 2014
COO and President at Global SPAC Partners Co, · on record since Apr 8, 2021
Director at Kaixin Holdings · on record since Oct 30, 2017
President and CFO at Kaixin Holdings · on record since Oct 30, 2017
CFO at BPGIC INTERNATIONAL · on record since Jun 19, 2018
10% owner at ACKRELL SPAC Partners I Co. · on record since Dec 28, 2020
Chief Operating Officer at ACKRELL SPAC Partners I Co. · on record since Dec 21, 2020
Chief Executive Officer at Better Therapeutics, Inc. · on record since Mar 17, 2021
10% owner at Better Therapeutics, Inc. · on record since Mar 17, 2021
Director at SOUNDHOUND AI, INC. · on record since Mar 12, 2021
Chief Executive Officer at SOUNDHOUND AI, INC. · on record since Mar 12, 2021
10% owner at SOUNDHOUND AI, INC. · on record since Mar 12, 2021
Director at Archimedes Tech SPAC Partners III Co. · on record since Jul 17, 2026

Insider trading activity of Cannon Stephen N

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Better Therapeutics, Inc.Listing unverified	Mar 17, 2021	Buy	330,000	10.00 USD	$3.3M	conv 41Cluster	SEC
Better Therapeutics, Inc.Listing unverified	Mar 17, 2021	BuyD (derivative)	165,000	—	n/a (No price was disclosed in the filing)	Cluster	SEC
ACKRELL SPAC Partners I Co.Listing unverified	Dec 28, 2020	Buy	470,000	10.00 USD	$4.7M	conv 43First in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Better Therapeutics, Inc.Listing unverified	Mar 17, 2021	Buy	330,000	10.00 USD	$3.3M	conv 41Cluster	SEC
Better Therapeutics, Inc.Listing unverified	Mar 17, 2021	BuyD (derivative)	165,000	—	n/a (No price was disclosed in the filing)	Cluster	SEC
ACKRELL SPAC Partners I Co.Listing unverified	Dec 28, 2020	Buy	470,000	10.00 USD	$4.7M	conv 43First in 12mo	SEC